Literature DB >> 12562854

Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins.

Eric E Niederkofler1, Kemmons A Tubbs, Urban A Kiernan, Dobrin Nedelkov, Randall W Nelson.   

Abstract

Novel mass spectrometric immunoassays (MSIAs) for the isolation and structural characterization of plasma apolipoprotein A-I (apoA-I), apoA-II, and apoE have been developed. The assays combine selective isolation of apolipoprotein species via affinity capture with mass-specific detection using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. In application, plasma (from 50 microl of whole blood drawn from individuals, using finger lancet) was addressed with affinity pipette tips derivatized with antibodies toward the specific apolipoprotein. The time required for each assay was approximately 15 min, less if assays on multiple individuals were performed in parallel. In a brief study of five individuals, several recently reported apoA-II variants were identified and observed consistently in all individuals. Additionally, the apoE phenotype of E3/E3 was observed in three of the individuals, and E2/E3 and E3/E4 observed in the remaining two individuals, the latter of whom suffers from Alzheimer's disease. Overall, the MSIA approach offers a rapid, sensitive, and highly accurate means of profiling apolipoproteins from small volumes of plasma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12562854     DOI: 10.1194/jlr.D200034-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  21 in total

1.  Examining serum amyloid P component microheterogeneity using capillary isoelectric focusing and MALDI-MS.

Authors:  Noah G Weiss; Jason W Jarvis; Randall W Nelson; Mark A Hayes
Journal:  Proteomics       Date:  2010-12-01       Impact factor: 3.984

2.  Investigating diversity in human plasma proteins.

Authors:  Dobrin Nedelkov; Urban A Kiernan; Eric E Niederkofler; Kemmons A Tubbs; Randall W Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

3.  Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.

Authors:  Chad R Borges; Jason W Jarvis; Paul E Oran; Stephen P Rogers; Randall W Nelson
Journal:  J Biomol Tech       Date:  2008-07

4.  Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies.

Authors:  Paul E Oran; Jason W Jarvis; Chad R Borges; Nisha D Sherma; Randall W Nelson
Journal:  Proteomics Clin Appl       Date:  2011-06-08       Impact factor: 3.494

Review 5.  Top-down proteomics in health and disease: challenges and opportunities.

Authors:  Zachery R Gregorich; Ying Ge
Journal:  Proteomics       Date:  2014-05       Impact factor: 3.984

6.  Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.

Authors:  Shannon K Flood-Nichols; Deborah Tinnemore; Mark A Wingerd; Ali I Abu-Alya; Peter G Napolitano; Jonathan D Stallings; Danielle L Ippolito
Journal:  Mol Cell Proteomics       Date:  2012-10-10       Impact factor: 5.911

7.  C-peptide microheterogeneity in type 2 diabetes populations.

Authors:  Paul E Oran; Jason W Jarvis; Chad R Borges; Randall W Nelson
Journal:  Proteomics Clin Appl       Date:  2009-11-11       Impact factor: 3.494

8.  Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.

Authors:  Ida Azizkhanian; Olgica Trenchevska; Yara Bashawri; Jiaqi Hu; Juraj Koska; Peter D Reaven; Randall W Nelson; Dobrin Nedelkov; Hussein N Yassine
Journal:  J Clin Lipidol       Date:  2016-03-08       Impact factor: 4.766

9.  Glycosylation status of vitamin D binding protein in cancer patients.

Authors:  Douglas S Rehder; Randall W Nelson; Chad R Borges
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

Review 10.  Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Authors:  Hussein Yassine; Chad R Borges; Matthew R Schaab; Dean Billheimer; Craig Stump; Peter Reaven; Serrine S Lau; Randall Nelson
Journal:  Proteomics Clin Appl       Date:  2013-07-09       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.